Xingui Liu
University of Florida
H-index: 15
North America-United States
Top articles of Xingui Liu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Design and optimization of piperlongumine analogs as potent senolytics | Bioorganic & Medicinal Chemistry Letters | Xuan Zhang Yonghan He Xingui Liu Xin Zhang Peizhong Shi | 2024/1/15 |
Therapeutic agents and methods of treatment | 2023/10/26 | ||
Proximity-based modalities for biology and medicine | Xingui Liu Alessio Ciulli | 2023/7/14 | |
Piperlongumine conjugates induce targeted protein degradation | Cell Chemical Biology | Jing Pei Yufeng Xiao Xingui Liu Wanyi Hu Amin Sobh | 2023/2/16 |
DUB be good to me | Nature Chemical Biology | Xingui Liu Alessio Ciulli | 2022/4 |
Discovery of XL01126: a potent, fast, cooperative, selective, orally bioavailable, and blood–brain barrier penetrant PROTAC degrader of leucine-rich repeat kinase 2 | Journal of the American Chemical Society | Xingui Liu Alexia F Kalogeropulou Sofia Domingos Nikolai Makukhin Raja S Nirujogi | 2022/8/25 |
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity | Nature communications | Dongwen Lv Pratik Pal Xingui Liu Yannan Jia Dinesh Thummuri | 2021/11/25 |
Mitigation of late cardiovascular effects of oxygen ion radiation by γ-tocotrienol in a mouse model | Life sciences in space research | Ashley S Nemec-Bakk Vijayalakshmi Sridharan Reid D Landes Preeti Singh Maohua Cao | 2021/11/1 |
Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition | Journal of medicinal chemistry | Pratik Pal Dinesh Thummuri Dongwen Lv Xingui Liu Peiyi Zhang | 2021/9/17 |
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies | Yonghan He Sajid Khan Zhiguang Huo Dongwen Lv Xuan Zhang | 2020/12 | |
Synthesis and Liver Microsomal Metabolic Stability Studies of a Fluorine‐Substituted δ‐Tocotrienol Derivative | ChemMedChem | Xingui Liu Saikat Poddar Lin Song Howard Hendrickson Xuan Zhang | 2020/3/18 |
Compositions and methods for selectively depleting senescent cells | 2020/9/1 | ||
Assays and technologies for developing proteolysis targeting chimera degraders | Xingui Liu Xuan Zhang Dongwen Lv Yaxia Yuan Guangrong Zheng | 2020/3 | |
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors | Peiyi Zhang Xuan Zhang Xingui Liu Sajid Khan Daohong Zhou | 2020 | |
Deuteration of the farnesyl terminal methyl groups of δ-tocotrienol and its effects on the metabolic stability and ability of inducing G-CSF production | Bioorganic & medicinal chemistry | Xingui Liu Zhengya Gao Qiang Fu Lin Song Peiyi Zhang | 2020/6/1 |
Targeting anti-apoptotic BCL-2 family proteins for cancer treatment | Xuan Zhang Xingui Liu Daohong Zhou Guangrong Zheng | 2020/1 | |
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity | Nature communications | Yonghan He Xuan Zhang Jianhui Chang Ha-Neui Kim Peiyi Zhang | 2020/4/24 |
A Facile Semisynthesis and Evaluation of Garcinoic Acid and Its Analogs for the Inhibition of Human DNA Polymerase β | Molecules | Satheesh Gujarathi Maroof Khan Zafar Xingui Liu Robert L Eoff Guangrong Zheng | 2020/12/11 |
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity | Dinesh Thummuri Xingui Liu Wanyi Hu Peiyi Zhang Sajid Khan | 2020/4/15 |
Co-Authors
